logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
delete
arrow
返回
C

Chih‐Hung Hsu

national taiwan university

52H指数
520论文数
1.6W被引数
收录论文 146
发表时间
logo
Nivolumab plus chemotherapy or ipilimumab versus chemotherapy as first-line treatment for advanced esophageal squamous cell carcinoma: 5-year follow-up results from CheckMate 648纳武利尤单抗联合化疗或伊匹木单抗对比化疗作为晚期食管鳞状细胞癌一线治疗的5年随访结果：CheckMate 648研究
errAnnals of Oncology
IF65.4
err2026-08-10
err0
errOAAI
errK. Kato; J. Ajani; Y. Doki; J. Xu; L. Wyrwicz; S. Motoyama; T. Ogata; H. Kawakami; C-H. Hsu; A. Adenis; F. el Hajbi; M. Di Bartolomeo; M. Ignez Braghiroli; E. Holtved; T. Makino; M. Blum Murphy; J. Zhang; P. Sharma; B. He; M. Lei
err分享
err收藏
Long-term survival of patients who received atezolizumab plus bevacizumab treatment for advanced hepatocellular carcinoma接受阿替利珠单抗联合贝伐珠单抗治疗晚期肝细胞癌患者的长期生存情况
errJournal of the Formosan Medical Association
IF2.5
err2025-11-07
err0
errOAAI
errChing-Tso Chen; Yin-Hsun Feng; Chia-Jui Yen; San-Chi Chen; Chih-Hung Hsu; Yu-Yun Shao
err分享
err收藏
Does chemotherapy regimen matter for first-line immunochemotherapy in low PD-L1-expressing esophageal squamous cell carcinoma? A systemic review and meta-analysis化疗方案对于PD-L1低表达的食管鳞状细胞癌的一线免疫化疗是否重要？一项系统评价和荟萃分析
errEsophagus
IF3.8
err2025-11-01
err0
errOAAI
errGuo, Jhe-Cyuan; Lin, Pei-Shan; Shau, Wen-Yi; Shao, Yu-Yun; Kuo, Hung-Yang; Chen, Chi-Ling; Hsu, Chih-Hung
err分享
err收藏
Enhancing Leanness Philosophies with Industry 5.0 Enables Reduction of Sustainable Supply Chain Risks: A Case Study of a New Energy Battery Manufacturer通过Industry 5.0增强精益理念以减少可持续供应链风险：一家新能源电池制造商的案例研究
errprocesses
IF0
err2025-08-17
err0
errOAAI
errDe-Xuan Zhu; Shao-Wei Huang; Chih-Hung Hsu; Qi-Hui Wu
err分享
err收藏
Personalized prediction of esophageal cancer risk based on virtually generated alcohol data基于虚拟生成酒精数据的食管癌风险个性化预测
errJOURNAL OF TRANSLATIONAL MEDICINE
IF7.5
err2025-03-28
err0
errOAAI
errNfor, Oswald Ndi; Huang, Pei-Ming; Wu, Ming-Fang; Chen, Ke-Cheng; Chou, Ying-Hsiang; Lin, Mong-Wei; Zhong, Ji-Han; Kuo, Shuenn-Wen; Lee, Yu-Kwang; Hsu, Chih-Hung; Lee, Jang-Ming
err分享
err收藏
Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with biliary tract cancer泛亚适应ESMO临床实践指南，用于胆道癌患者的诊断，治疗和随访
errESMO OPEN
IF8.3
err2024-08-01
err0
errOAAI
errChen, L. -T; Vogel, A.; Hsu, C.; Chen, M. -h.; Fang, W.; Pangarsa, E. A.; Sharma, A.; Ikeda, M.; Park, J. O.; Tan, C. K.; Regala, E.; Tai, D.; Tanasanvimon, S.; Charoentum, C.; Chee, C. E.; Lui, A.; Sow, J.; Oh, D. -y.; Ueno, M.; Ramaswamy, A.; Jeo, W. S.; Zhou, J.; Curigliano, G.; Yoshino, T.; Bai, L. -y.; Pentheroudakis, G.; Chiang, N. -j.; Cervantes, A.; Chen, J. -s.; Ducreux, M.
err分享
err收藏
Cyclin dependent kinase 9 inhibition reduced programmed death-ligand 1 expression and improved treatment efficacy in hepatocellular carcinoma抑制细胞周期蛋白依赖性激酶9可减少程序性死亡配体1的表达并提高肝细胞癌的治疗效果
errHELIYON
IF3.6
err2024-07-01
err1
errOAAI
errShao, Yu-Yun; Hsieh, Min-Shu; Lee, Yi-Hsuan; Hsu, Hung-Wei; Wo, Rita Robin; Wang, Han-Yu; Cheng, Ann-Lii; Hsu, Chih-Hung
err分享
err收藏
Bintrafusp alfa and chemotherapy as first-line treatment in biliary tract cancer: A randomized phase 2/3 trial
errHEPATOLOGY
IF15.8
err2024-06-14
err0
errOAAI
errOh, Do-Youn; Ikeda, Masafumi; Lee, Choong-kun; Rojas, Carlos; Hsu, Chih-Hung; Kim, Jin Won; Shen, Lin; Furuse, Junji; Park, Joon Oh; Borad, Mitesh; de Braud, Filippo; Bridgewater, John; Lee, Sunyoung S.; Moehler, Markus; Audhuy, Francois; Osada, Motonobu; Sato, Masashi; Yoo, Changhoon
err分享
err收藏
Changes in Posttreatment Spleen Volume Associated with Immunotherapy Outcomes for Advanced Hepatocellular Carcinoma晚期肝癌治疗后脾脏体积变化与免疫治疗结局的相关性
errJOURNAL OF HEPATOCELLULAR CARCINOMA
IF3.4
err2024-06-01
err1
errOAAI
errChen, Bang-Bin; Liang, Po-Chin; Shih, Tiffany Ting-Fang; Liu, Tsung-Hao; Shen, Ying-Chun; Lu, Li -Chun; Lin, Zhong-Zhe; Hsu, Chiun; Hsu, Chih-Hung; Cheng, Ann-Lii; Shao, Yu-Yun
err分享
err收藏
NGM707 in combination with pembrolizumab in advanced or metastatic solid tumors: Preliminary results from dose escalation
errCANCER RESEARCH
IF16.6
err2024-04-05
err0
PREAI
errWang, Judy S.; Sharma, Manish R.; Edenfield, William J.; Sehgal, Kartik; Oh, Do-Youn; Jiang, Yixing; Michalski, Joel; Lee, Jeeyun; Hammers, Hans; Bai, Li-Yuan; Hsu, Chih-Hung; Dampier, Brenda; Zhou, Kefei; Yan, Li; Blum, Lisa K.; Sloan-Lancaster, Joanne; Kaplan, Daniel D.; Abhyankar, Dhiraj; Lieu, Hsiao D.; Hanes, Vladimir; Naing, Aung
err分享
err收藏
Safety of prompt initiation of durvalumab or STRIDE (single tremelimumab regular interval durvalumab) regimen as hepatocellular carcinoma (HCC) treatment for patients with chronic active hepatitis B
errCANCER RESEARCH
IF16.6
err2024-04-05
err0
PREAI
errShao, Yu-Yun; Chen, Ching-Tso; Wu, Tsung-Che; Liu, Tsung-Hao; Chuang, Chien-Huai; Cheng, Ann-Lii; Hsu, Chih-Hung
err分享
err收藏
Nivolumab in sorafenib-naive and sorafenib-experienced patients with advanced hepatocellular carcinoma: 5-year follow-up from CheckMate 040
errANNALS OF ONCOLOGY
IF65.4
err2024-04-01
err11
errOAAI
errEl-Khoueiry, A. B.; Trojan, J.; Meyer, T.; Yau, T.; Melero, I.; Kudo, M.; Hsu, C.; Kim, T. -y.; Choo, S. -p.; Kang, Y. -k.; Yeo, W.; Chopra, A.; Soleymani, S.; Yao, J.; Neely, J.; Tschaika, M.; Welling, T. H.; Sangro, B.
err分享
err收藏
Tertiary lymphoid structure associates with poor prognosis in locally advanced esophageal squamous cell carcinoma treated with neoadjuvant chemoradiotherapy
errCANCER RESEARCH
IF16.6
err2024-03-22
err0
PREAI
errHuang, Ta-Chen; Liang, Cher-Wei; Li, Yu-I; Guo, Jhe-Cyuan; Lin, Chia-Chi; Lee, Jang-Ming; Chao, Yin-Kai; Hsu, Chih-Hung
err分享
err收藏
The distinct tumor microenvironment of advanced hepatocellular carcinoma with high PVR or high PD-L1 expression
errCANCER RESEARCH
IF16.6
err2024-03-22
err0
PREAI
errLu, Li-Chun; Lee, Yi-Hsuan; Liu, Tsung-Hao; Shao, Yu-Yun; Cheng, Ann-Lii; Hsu, Chih-Hung
err分享
err收藏
Outcomes of Post-Immunotherapy Durable Responders of Advanced Hepatocellular Carcinoma- with Emphasis on Locoregional Therapy for Oligoprogression晚期肝细胞癌的免疫治疗后持久反应的结果-强调局部区域治疗的寡进展
errLIVER CANCER
IF9.1
err2024-02-01
err0
errOAAI
errLiu, Tsung-Hao; Chen, San-Chi; Rau, Kun-Ming; Lu, Li-Chun; Lin, Po-Ting; Su, Yung-Yeh; Teng, Wei; Lai, Shiue-Wei; Yeh, Ren-Hua; Kao, Tsui-Mai; Lee, Pei-Chang; Wu, Chi-Jung; Chen, Chien-Hung; Hsu, Chih-Hung; Lin, Shi-Ming; Huang, Yi-Hsiang; Chen, Li-Tzong; Cheng, Ann-Lii; Shen, Ying-Chun
err分享
err收藏
Prognostication and optimal criteria of circumferential margin involvement for esophageal cancer after chemoradiation and esophagectomy食管癌放化疗和食管切除术后环周切缘受累的预后和最佳标准
errFRONTIERS IN ONCOLOGY
IF3.3
err2023-07-12
err0
errOAAI
errPotdar, Ankit; Chen, Ke-Cheng; Kuo, Shuenn-Wen; Lin, Mong-Wei; Liao, Hsien-Chi; Huang, Pei-Ming; Lee, Yi-Hsuan; Wang, Hsiu-Po; Han, Ming-Lun; Cheng, Chia-Hsien; Hsu, Chih-Hung; Huang, Ta-Chen; Hsu, Feng-Ming; Lu, Shao-Lun; Lee, Jang-Ming
err分享
err收藏
Association of tumor mutational burden (TMB) and clinical outcomes with tislelizumab versus chemotherapy in esophageal cell carcinoma (ESCC) from RATIONALE-302
errCANCER RESEARCH
IF16.6
err2023-04-14
err0
PREAI
errShen, Lin; Shu, Yongqian; Zhao, Kuaile; Satoh, Taroh; Chen, Zhendong; Van Cutsem, Eric; Yu, Guohua; Wu, Jun; Hsu, Chih-Hung; Kim, Sung Bae; Du, Wenting; Shi, Yang; Huang, Ruiqi; Li, Qiao; Shi, Jingwen; Zhang, Yun; Ken, Kato
err分享
err收藏
Cyclin dependent kinase 9 (CDK9) inhibition increased efficacy of programmed cell death protein 1 (PD-1) blockade for hepatocellular carcinoma (HCC) through decreasing programmed death-ligand 1 (PD-L1) expression
errCANCER RESEARCH
IF16.6
err2023-04-04
err0
PREAI
errChen, Ching-Tso; Shao, Yu-Yun; Hsu, Hung-Wei; Wo, Rita R.; Wang, Han-Yu; Cheng, Ann-Lii; Hsu, Chih-Hung
err分享
err收藏
Evolution of immune tumor microenvironment (TME) from esophageal dysplasia to esophageal squamous cell carcinoma (ESCC)
errCANCER RESEARCH
IF16.6
err2023-04-04
err0
PREAI
errGuo, Jhe-Cyuan; Hsu, Chia-Lang; Huang, Yen-Lin; Wu, Tsung-Che; Hsu, Chih-Hung
err分享
err收藏
The prognostic role of tertiary lymphoid structure (TLS) in locally advanced esophageal squamous cell carcinoma (ESCC)
errCANCER RESEARCH
IF16.6
err2023-04-04
err1
PREAI
errHuang, Ta-Chen; Liang, Cher-Wei; Li, Yu-I; Guo, Jhe-Cyuan; Lin, Chia-Chi; Lee, Jang-Ming; Chao, Yin-Kai; Hsu, Chih-Hung
err分享
err收藏

研究方向

暂时未获取到该数据
合作学者
合作期刊
E
Eric Van Cutsem
H 指数: 174 · 论文数: 1.8K
J
Johann S. de Bono
H 指数: 160 · 论文数: 2.5K
J
Jaffer A. Ajani
H 指数: 152 · 论文数: 1.7K
J
Josep M. Llovet
H 指数: 151 · 论文数: 794
M
Masatoshi Kudo
H 指数: 143 · 论文数: 2.8K
查看更多